Pharma & Bio
Lifestyle
Lunit Inc. and DRTECH Corporation Rise on Improved Earnings… Curiox Down 20% Amid Litigation Uncertainty [Bio Market Watch]
On the 13th, in the pharmaceutical and biotech sector, shares of Lunit Inc.(328130)and DRTECH Corporation(214680)rose in tandem, driven by improved earnings. Lunit Inc. attracted investor interest due…
- 2026-11-16 07:42:02
- Kim Jinsoo
Technology
Aston and Bertis Choose Their Path… They Started by Looking at Companies to Acquire in the Tech Sector
Even as it has become increasingly difficult for biotech startups to secure funding, there are venture capital (VC) firms that remain active in biotech investments. One such firm is Pathway Partners (…
- 2026-11-16 07:21:02
- NA EUN-KYUNG
Lifestyle
[Exclusive] From 25-Year Allies to Enemies… What Happened Between OSCOTEC Inc.’s Largest Shareholder and CEO? [OSCOTEC Inc. Conflict]
Even during the flight from Boston to Seoul—which lasted over 12 hours—he stayed awake all night, unable to sleep, and remained in constant contact. Although his day-night cycle was frequently disrupt…
- 2026-11-16 07:01:02
- Kim Jinsoo
Lifestyle
Rookie Baropharm and Embattled Moalife Plus Face Paradoxical Volatility as GC Genome Anchors the Market [K-Bio Pulse]
Amid broader market volatility on Thursday, South Korea’s biopharmaceutical sector lacked a clear directional trend, leaving traditional, profitable pharmaceutical and biotech firms to anchor investor…
- 2026-11-14 12:47:03
- YU JIN-HEE
Lifestyle
Newcomer BaroPharm and MoaLife in the Home Stretch Show Paradoxical ‘Hot Streak’... GC Genome Corporation Holds Steady [Bio Spotlight]
On the 12th, as the domestic securities market continued to show mixed trends and the biotech sector also failed to establish a clear direction, traditional pharmaceutical and biotech companies with s…
- 2026-11-14 12:47:02
- YU JIN-HEE
Technology
SK BIOPHARMACEUTICALS’ ‘Senobamate’ Sees Expansion of Indications for Children and Adolescents, but Hits a Snag in Europe... Why?
(Graphic: ChatGPT)
Procedures are underway in Europe and the United States to expand the approved use of SK BIOPHARMACEUTICALS(326030)’s epilepsy treatment, cenobamate, to include children and ado…
- 2026-11-14 07:31:02
- Minji Son
Lifestyle
[Exclusive] Hwang Man-hoe, CEO of ADBIOTECH Co.,Ltd., Charged with Fraud and Obstruction of Business
ADBIOTECH Co.,Ltd.(179530), a KOSDAQ-listed company that had been seeking to improve its business fundamentals through management restructuring and business diversification, has become embroiled in a …
- 2026-11-13 12:01:02
- YU JIN-HEE
Technology
MedPacto Hits Limit-Up on Cancer Drug Data, Curiosis Rebounds on ODM Hopes [K-Bio Pulse]
On November 11, South Korean pharmaceutical, biotech, and healthcare stocks rose across the board amid a market rebound. MedPacto surged after preclinical findings for its cancer drug candidate MP010 …
- 2026-11-13 07:37:04
- Minji Son
Technology
MedPacto, Inc. Soars on Preclinical Results… Curiosis Inc. Also Rebounds on Global Business Expectations [Bio Spotlight]
On the 11th, domestic pharmaceutical, biotech, and healthcare stocks showed strength, buoyed by a general market rebound. MedPacto, Inc.(235980)is believed to have seen its stock price rise as expecta…
- 2026-11-13 07:37:02
- Minji Son
Lifestyle
“1 Billion Cells” AI Training Data: Psomagen, Inc.’s Share Grows
Psomagen, Inc.(950200) ’s role has expanded in a project by the Chan Zuckerberg Initiative (CZI)—founded by Mark Zuckerberg and Priscilla Chan—to train biological artificial intelligence (AI) using 1 …
- 2026-11-13 06:41:02
- KIM JI-WAN
PHARM EDAILY
Shorts